AI Science Tracker

University of Helsinki

2 discoveries from 2024 to 2026

Discoveries

Machine learning guides discovery of selective submicromolar CK2 inhibitors

The accepted-paper abstract reports that docking, CDK-liability filtering, machine learning and error prediction guided more selective CK2 inhibitor leads. The authors report submicromolar hits and a 90% pipeline hit rate; kinase-assay figures support biochemical inhibition. These are discovery-stage compounds, with no demonstrated clinical benefit. The hit rate describes the authors' selected pipeline, not a general drug-discovery success rate.

Technology: Machine learning; prediction-error modeling; molecular docking

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Kinase-assay figures report CK2 inhibition by selected hit compounds.
  • Still unknown: Full study methods, independent reproduction and clinical outcomes were not assessed.
  • AI role: ML and error prediction prioritized compounds after docking and off-target filtering.

Evidence sources: https://www.nature.com/articles/s42004-026-02268-0 · https://www.nature.com/articles/s42004-026-02268-0_reference.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Machine learning identifies alkaline laccases from Lepista nuda

Machine-learning pH-optimum predictors screened metagenomic sequences, and two predicted Lepista nuda laccases were produced and profiled. The authors report LnLccA and LnLccB optimum activity at pH 10 and 9 for substrate 2,6-DMP, respectively, while both had pH 4 optima for ABTS. The substrate-dependent contrast is retained; it is not a general alkaline optimum or industrial demonstration.

Technology: Supervised, semi-supervised and unsupervised pH-optimum prediction models

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Open primary full article reports recombinant LnLccA and LnLccB pH profiles, substrate-specific optima and validation of ML predictions.
  • Still unknown: Prior characterization and novelty of sequence/activity remain open; industrial applicability not demonstrated.
  • AI role: Models trained on curated laccase pH data predicted candidates from metagenomic sequences that were expressed and profiled.

Evidence sources: https://link.springer.com/article/10.1186/s13068-024-02566-6

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: Primary source checked for identity, date, model role and bounded reported result..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.